Venmax Drugs Pharmaceuticals Ltd vs Zenotech Laboratories Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Venmax Drugs & Pharmaceuticals Ltd is ₹ 24.55 as of 04 May 11:22 . The P/E Ratio of Venmax Drugs & Pharmaceuticals Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Zenotech Laboratories Ltd changed from 13.9 on March 2022 to 56.4 on March 2025 . This represents a CAGR of 41.93% over 4 years The Market Cap of Venmax Drugs & Pharmaceuticals Ltd changed from ₹ 14.94 crore on March 2025 to ₹ 14.94 crore on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe Market Cap of Zenotech Laboratories Ltd changed from ₹ 213.61 crore on March 2021 to ₹ 316.87 crore on March 2025 . This represents a CAGR of 8.21% over 5 years The revenue of Venmax Drugs & Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 1.62 crore. This represent the decline of -100% The revenue of Zenotech Laboratories Ltd for the Mar '26 is ₹ 10.53 crore as compare to the Dec '25 revenue of ₹ 13.28 crore. This represent the decline of -20.71% The ebitda of Venmax Drugs & Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0.04 crore. This represent the decline of -100% The ebitda of Zenotech Laboratories Ltd for the Mar '26 is ₹ 0.82 crore as compare to the Dec '25 ebitda of ₹ 4.39 crore. This represent the decline of -81.32% The net profit of Venmax Drugs & Pharmaceuticals Ltd changed from ₹ 0.01 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The net profit of Zenotech Laboratories Ltd changed from ₹ 1.29 crore to ₹ -3.15 crore over 8 quarters. This represents a CAGR of NaN% The Dividend Payout of Venmax Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Zenotech Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Venmax Drugs & Pharmaceuticals Ltd

Venmax Drugs & Pharmaceuticals Limited, (VDPL) was initially incorporated as Private Company as 'Yenkay Medico Private Limited', on 28 September, 1998.
The Company thereafter changed its name to 'Yenkey Drugs & Pharmaceuticals Private Limited' on 18 January, 1995.
It became a Public Limited Company on February 3, 1995 as 'Yenkey Drugs & Pharmaceuticals Limited'.
Finally, the Company changed its name to 'Venmax Drugs & Pharmaceuticals Limited' on April 13, 2009. For the past six months, Company focused on establishing chain of Medical Stores with a brand name as 'Ananya Pharma' under the Venmax Drugs & Pharma Limited, with the backing support of Formulations plant (Suzichem Labs).
At present, Company is engaged in the business of pharmaceutical products, drug intermediaries & API's etc. The Company is developing the oncology products in R&D.

About Zenotech Laboratories Ltd

Zenotech Laboratories Limited was initially established as Sunline Technologies Limited in June, 1989 and changed to the present name w.e.f.
August 9, 2004.
Company is a loan licensing company catering exclusively to Sun Pharmaceutical Industries Limited, Promoter & holding company and they are specialized contract manufacturing services /processing in parenteral depot formulations, ophthalmic, oncology oral & injectables and general injectables.
Company's injectables product portfolio primarily serves niche therapy areas like oncology and anesthesiology. During financial year 2004-05, the Hon'ble High Court of Andhra Pradesh sanctioned the Scheme of Amalgamation with M/s.
Zenotech Technologies Limited with effect from November 1st , 2003.

FAQs for the comparison of Venmax Drugs & Pharmaceuticals Ltd and Zenotech Laboratories Ltd

Which company has a larger market capitalization, Venmax Drugs & Pharmaceuticals Ltd or Zenotech Laboratories Ltd?

Market cap of Venmax Drugs & Pharmaceuticals Ltd is 28 Cr while Market cap of Zenotech Laboratories Ltd is 266 Cr

What are the key factors driving the stock performance of Venmax Drugs & Pharmaceuticals Ltd and Zenotech Laboratories Ltd?

The stock performance of Venmax Drugs & Pharmaceuticals Ltd and Zenotech Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Venmax Drugs & Pharmaceuticals Ltd and Zenotech Laboratories Ltd?

As of May 4, 2026, the Venmax Drugs & Pharmaceuticals Ltd stock price is INR ₹24.51. On the other hand, Zenotech Laboratories Ltd stock price is INR ₹43.61.

How do dividend payouts of Venmax Drugs & Pharmaceuticals Ltd and Zenotech Laboratories Ltd compare?

To compare the dividend payouts of Venmax Drugs & Pharmaceuticals Ltd and Zenotech Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.